cytostatic drugs under clinical trial [ elobromol ( dbd ) , myelobromol ( dbm ) , lycurim ( ly ) , zitostop ( zi ) ] , others in preclinical analysis [ dianhydrogalactitol ( dag ) , 3,4-diacetyldianhydrogalactitol ( diacdag ) , 3,4-disuccinyldianhydrogalactitol ( disudag ) ] , and compounds without any known antitumor effect in transplantable tumors [ 1-bromo-3,6-anhydrodulcitol ( bad ) , 1,2-epoxi-3,6-anhydrodulcitol ( ead ) ] were examined .
C0878349
elobromol
C0026252
dbd